Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

SELL
$67.66 - $84.76 $6,968 - $8,730
-103 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$67.06 - $75.82 $19,916 - $22,518
-297 Reduced 74.25%
103 $7,000
Q1 2021

May 06, 2021

BUY
$67.06 - $75.82 $26,824 - $30,327
400 New
400 $20,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Grandview Asset Management LLC Portfolio

Follow Grandview Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandview Asset Management LLC with notifications on news.